GIC Private Ltd - 18 Dec 2025 Form 4 Insider Report for Medline Inc. (MDLN)

Reporting relationship: 10%+ Owner
Issuer ticker: MDLN
Reported as of: 18 Dec 2025
Net transaction value: +$75,519,884
SEC form: 4
Accepted by SEC: 22 Dec 2025, 17:26:57 UTC
Prior SEC filing: 17 Dec 2025
Next SEC filing: 02 Feb 2026
Source filing: View source filing
Reporting owner signature: GIC Private Ltd, By: /s/ Jo-Ann Khor Hey Ming, Name: Jo-Ann Khor Hey Ming, Title: Senior Vice President; By: /s/ Lim Bee Peng, Name: Lim Bee Peng, Title: Senior Vice President

Key filing fact

GIC Private Ltd filed Form 4 for Medline Inc. (MDLN) on 22 Dec 2025.

Key facts

This page summarizes GIC Private Ltd's Form 4 filing for Medline Inc. (MDLN).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 Dec 2025, 17:26.

Change

Previous filing in this sequence was filed on 17 Dec 2025.
Current net transaction value: +$75,519,884.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (3)

CIK 0000936828 Primary reporting owner

GIC Private Ltd

Relationship: 10%+ Owner
Address: 168 ROBINSON ROAD, #37-01 CAPITAL TOWER, SINGAPORE, SINGAPORE
Signature: GIC Private Ltd, By: /s/ Jo-Ann Khor Hey Ming, Name: Jo-Ann Khor Hey Ming, Title: Senior Vice President; By: /s/ Lim Bee Peng, Name: Lim Bee Peng, Title: Senior Vice President
Signature date: 22 Dec 2025

CIK 0001296212

GIC Special Investments Pte Ltd

Relationship: 10%+ Owner
Address: 168 ROBINSON ROAD, #37-01 CAPITAL TOWER, SINGAPORE, SINGAPORE
Signature: GIC Special Investments Pte Ltd, By: /s/ Sensen Lin, Name: Sensen Lin, Title: Authorized Signatory for GIC SI
Signature date: 22 Dec 2025

CIK 0002038483

Hux Investment Pte. Ltd.

Relationship: 10%+ Owner
Address: 168 ROBINSON ROAD, #37-01 CAPITAL TOWER, SINGAPORE, SINGAPORE
Signature: Hux Investment Pte. Ltd., By: /s/ Suresh Bala, Name: Suresh Bala, Title: Director
Signature date: 22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN transaction

Class A Common Stock

Sale

Transaction value: $289,480,090
Shares: -10,204,351
Change %: -10%
Price: $28.37
Shares after: 91,555,447
Date: 18 Dec 2025
Ownership: Hux Investment Pte. Ltd.
Footnotes: F1, F3, F4

MDLN transaction

Class A Common Stock

Purchase

Transaction value: $364,999,974
Shares: +12,586,206
Change %: +86%
Price: $29.00
Shares after: 27,241,378
Date: 18 Dec 2025
Ownership: Direct
Footnotes: F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This amount represents the $29.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.63173 per share sold by Hux Investment Pte. Ltd. ("Hux") to the Issuer in connection with the Issuer's initial public offering ("IPO").

Footnote F2

On December 18, 2025, GIC Private Limited ("GIC") purchased 12,586,206 shares of Class A Common Stock in the IPO.

Footnote F3

These securities are owned directly by Hux. Hux shares the power to vote and the power to dispose of these securities with GIC Special Investments Pte. Ltd. ("GIC SI") and GIC (with Hux and GIC SI, each a "Reporting Person"), both of which are private limited companies incorporated in Singapore. GIC SI is wholly owned by GIC and is the private equity investment arm of GIC. GIC is wholly owned by the Government of Singapore and was set up with the sole purpose of managing Singapore's foreign reserves. The Government of Singapore disclaims beneficial ownership of these securities.

Footnote F4

Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.